Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy
Clinical trial NCT01565096 · UNKNOWN
Trial details
- NCT number
- NCT01565096
- Sponsor
- ikfe-CRO GmbH
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-11-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.